Towards an optimization of the management of endocrine complications of thalassemia
-
Mohamed El Kholy
,
Ashraf Soliman
Abstract
Children with thalassemia are living longer due to better care. Physicians dealing with this group of patients now have to contend with new challenges resulting from iron overload. Endocrine complications represent the most common morbidities encountered. To provide a better quality of life, these complications have to be addressed in a consistent way. For this purpose, we have compiled a set of recommendations to help physicians provide the best care possible to these patients.
References
1. De Sanctis V, Eleftheriou A, Malaventura C. Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). Pediatr Endocrinol Rev 2004;2:249–55.Search in Google Scholar
2. Hershko C, Link G, Cabantchik I. Pathophysiology of iron overload. Ann N Y Acad Sci 1998;30:191–201.10.1111/j.1749-6632.1998.tb10475.xSearch in Google Scholar PubMed
3. Andrews NC, Schmidt PJ. Iron homeostasis. Ann Rev Physiol 2007;69:69–85.10.1146/annurev.physiol.69.031905.164337Search in Google Scholar PubMed
4. Magro S, Puzzonia P, Consarino C, Galati MC, Morgione S, et al. Hypothyroidism in patients with thalassaemia syndromes. Acta Haematol 1990;84:72–6.10.1159/000205032Search in Google Scholar PubMed
5. De Sanctis V, Elawwa A, Angastiniotis M, Eleftheriou A, Kattamis C, et al. Highlights from the First Thalassaemia Forum on Growth and Endocrine Complications in Thalassemia Doha (October 2–3, 2011). Pediatr Endocrinol Rev 2012;9:672–9.Search in Google Scholar
6. De Sanctis V. Growth and puberty and its management in thalassaemia. Horm Res 2002;58:72–9.10.1159/000064766Search in Google Scholar PubMed
7. Wonke B, De Sanctis V. Clinical aspects of transfusional iron overload. Clin Exp Hematol 2001;12:322–34.Search in Google Scholar
8. Soliman AT, Khalafallah H, Ashour R. Growth and factors affecting it in thalassemia major. Hemoglobin 2009;33:S116–26.10.3109/03630260903347781Search in Google Scholar PubMed
9. De Sanctis V, Vullo C, Bagni B, Chiccoli L. Hypoparathyroidism in beta-thalassemia major. Clinical and laboratory observations in 24 patients. Acta Haematol 1992;88:105–8.Search in Google Scholar
10. De Sanctis V, Borsari G, Brachi S, Gubellini E, Gamberini MR, et al. A rare cause of heart failure in iron-overload thalassaemic patients-primary hypoparathyroidism. Georgian Med News 2008;156:111–3.Search in Google Scholar
11. De Sanctis V, Savarino L, Stea S, Cervellati M, Ciapetti G, et al. Microstructural analysis of severe bone lesions in seven thalassaemic patients treated with desferrioxamine. Calcif Tissue Ital 2000;67:128–33.10.1007/s00223001122Search in Google Scholar PubMed
12. Skordis N. Endocrine investigation and follow up in thalassaemia. Time for specific guidelines. Thalassemia Rep 2011;1:e22.10.4081/thal.2011.s2.e22Search in Google Scholar
13. De Sanctis V, Wonke B. Growth and endocrine complications in thalassaemia. Rome: Mediprint, 1998.Search in Google Scholar
14. Karimi M, Rasekhi AR, Rasekh M, Nabavizadeh SA, Assadsangabi R, et al. Hypoparathyroidism and intracerebral calcification in patients with beta-thalassemia major. Eur J Radiol 2009;70:481–4.10.1016/j.ejrad.2008.02.003Search in Google Scholar PubMed
15. Skordis N, Loannou YS, Kyriakou A, Savva SC, Efstathiou E et al. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major. Pediatr Endocrinol Rev 2008;6:144–8.Search in Google Scholar
16. Smaldone A. Glycemic control and hemoglobinopathy: when A1C may not be reliable. Diabetes Spect 2008;21:46–9.10.2337/diaspect.21.1.46Search in Google Scholar
17. Incorvaia C, Parmeggiani F, Mingrone G, Sebastiani A, De Sanctis V. Prevalence of retinopathy in diabetic thalassaemic patients. J Pediatr Endocrinol Metab 1998;11:879–83.Search in Google Scholar
18. Poomthavorn P, Isaradisaikul B, Chuansumrit A, Khlairit P, Sriphrapradang A, et al. High prevalence of “biochemical” adrenal insufficiency in thalassemics: Is it a matter of different testings or decreased cortisol binding globulin? J Clin Endocrinol Metab 2010;95:4609–15.10.1210/jc.2010-0205Search in Google Scholar PubMed
19. Elsedfy HH, El Kholy M, Tarif R, Hamed A, Elalfy M. Adrenal function in thalassemia major adolescents. Pediatr Endocrinol Rev 2011;8:295–9.Search in Google Scholar
20. Toumba M, Kanaris C, Simamonian K, Skordis N. Outcome and management of pregnancy in women with thalassaemia in Cyprus. East Med Health J 2008;14:628–35.Search in Google Scholar
21. Skordis N, Christou S, Koliou M, Pavlides N, Angastiniotis M. Fertility in female patients with thalassaemia. J Ped Endocrinol Metab 1998;11:935–43.Search in Google Scholar
22. Skordis N, Petrikkos L, Toumba M, Hadjigavriel M, Sitarou M, et al. Update on fertility in thalassaemia major. Pediatr Endocrinol Rev 2004;2:296–302.Search in Google Scholar
23. De Sanctis V, Vullo C, Katz M, Wonke B, Nannetti C, et al. Induction of spermatogenesis in thalassaemia. Fertil Steril 1998;50:969–75.10.1016/S0015-0282(16)60382-5Search in Google Scholar
24. Soliman AT, Nasr I, Thabet A, Rizk MM, El Matary W. Human chorionic gonadotropin therapy in adolescent boys with constitutional delayed puberty vs. those with beta-thalassemia major. Metabolism 2005;54:15–23.10.1016/j.metabol.2004.07.006Search in Google Scholar PubMed
25. De Sanctis V, Soliman AT, Angastiniotis M, Eleftheriou A, Kattamis Ch, et al. International network on endocrine complications in thalassaemia (I-CET): an opportunity to grow. Georgian Med News 2012;205:52–7.Search in Google Scholar
26. Standards for the clinical care of children and adult with thalassaemia in UK, 2nd ed. UK: United Kingdom Thalassaemia Society, 2008. Available at: http://www.ukts.org (accessed 1 May 2014).Search in Google Scholar
27. Guidelines for the clinical management of thalassaemia, 2nd ed. Cyprus: Thalassaemia International Federation, 2008. Available at: http://www.thalassaemia.org.cy (accessed 1 May 2014).Search in Google Scholar
28. Standards of care guidelines for thalassaemia. Oakland, CA: Children’s Hospital & Research Center Oakland, 2009. Available at: http://www.thalassemia.org (accessed 1 May 2014).Search in Google Scholar
29. Guidelines for the clinical care of patients with thalassemia in Canada. Canada: Thalassemia Foundation of Canada, 2009. Available at: http://www.thalassemia.ca (accessed 1 May 2014).Search in Google Scholar
©2014 by De Gruyter
Articles in the same Issue
- Frontmatter
- Review article
- Towards an optimization of the management of endocrine complications of thalassemia
- Original articles
- The natural course of Hashimoto’s thyroiditis in children and adolescents
- Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
- Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
- Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
- Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
- Pubertal development profile in patients with Turner syndrome
- A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
- Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
- Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
- Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
- Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
- Permanent neonatal diabetes mellitus in Jordan
- The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
- The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
- The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
- Lipid patterns in treated growth hormone deficient children vs. short stature controls
- Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
- Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
- Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
- Patient reports
- A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
- Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
- Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
- Growth hormone treatment in a patient with Hurler-Scheie syndrome
- Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
- Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
- Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
- Cushing’s syndrome: hidden risk in usage of topical corticosteroids
- Prader-Willi syndrome: a case report with atypical developmental features
- Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
- Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
- Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
- Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
- A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
- Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
- Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
- Short communication
- An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
- Letter to the Editor
- Pubertal gynecomastia: what about the remaining 10%?
Articles in the same Issue
- Frontmatter
- Review article
- Towards an optimization of the management of endocrine complications of thalassemia
- Original articles
- The natural course of Hashimoto’s thyroiditis in children and adolescents
- Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
- Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
- Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
- Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
- Pubertal development profile in patients with Turner syndrome
- A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
- Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
- Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
- Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
- Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
- Permanent neonatal diabetes mellitus in Jordan
- The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
- The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
- The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
- Lipid patterns in treated growth hormone deficient children vs. short stature controls
- Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
- Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
- Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
- Patient reports
- A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
- Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
- Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
- Growth hormone treatment in a patient with Hurler-Scheie syndrome
- Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
- Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
- Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
- Cushing’s syndrome: hidden risk in usage of topical corticosteroids
- Prader-Willi syndrome: a case report with atypical developmental features
- Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
- Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
- Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
- Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
- A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
- Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
- Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
- Short communication
- An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
- Letter to the Editor
- Pubertal gynecomastia: what about the remaining 10%?
